The latest update is out from Respiri Limited ( (AU:RSH) ).
Respiri Limited announced that recent U.S. health policy developments and international trade conditions bolster its commercial strategy and operational resilience. U.S. Health Secretary Robert F. Kennedy Jr.’s endorsement of AI and telehealth solutions aligns with Respiri’s Connected Care model, promoting virtual care technologies in rural areas. Despite new U.S. tariffs on Chinese medical devices, Respiri’s operations remain unaffected due to its substantial inventory and cost absorption strategy, ensuring stable pricing and uninterrupted service for clients.
More about Respiri Limited
Respiri Limited is an eHealth company that specializes in delivering Connected Care and Chronic Condition Management through remote patient monitoring across the U.S. healthcare system. The company is a pioneer in medical devices and MedTech, focusing on innovative solutions like the wheezo® medical device for respiratory disorders. Respiri collaborates with healthcare providers to integrate advanced technologies into existing systems, aiming to enhance patient care and reduce healthcare costs.
YTD Price Performance: 4.00%
Technical Sentiment Signal: Sell
Current Market Cap: $32.22M
See more data about RSH stock on TipRanks’ Stock Analysis page.